Phase I trial of neoadjuvant and postoperative paclitaxel (P), carboplatin (C) and erlotinib with concurrent accelerated hyperfractionation radiation (AHFR) followed by erlotinib maintenance therapy in stage III non-small cell lung cancer (NSCLC)
2005 ◽
Vol 23
(16_suppl)
◽
pp. 2091-2091
Keyword(s):
Phase I
◽